# Bortezomib in Treating Patients With Metastatic Kidney Cancer

> **NCT00276614** · PHASE2 · COMPLETED · sponsor: **Jonsson Comprehensive Cancer Center** · enrollment: 4 (actual)

## Conditions studied

- Kidney Cancer

## Interventions

- **DRUG:** bortezomib

## Key facts

- **NCT ID:** NCT00276614
- **Lead sponsor:** Jonsson Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2020-09-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00276614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00276614, "Bortezomib in Treating Patients With Metastatic Kidney Cancer". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT00276614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*